Cell Source, Inc.
CLCS
$0.25
-$0.02-7.41%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 25.98% | -52.21% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.33% | 4.89% | |||
| Operating Income | 30.33% | -4.89% | |||
| Income Before Tax | 4.82% | -16.73% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 4.82% | -16.73% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.82% | -16.73% | |||
| EBIT | 30.33% | -4.89% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 6.50% | -12.63% | |||
| Normalized Basic EPS | 7.05% | -15.23% | |||
| EPS Diluted | 6.50% | -12.63% | |||
| Normalized Diluted EPS | 7.05% | -15.23% | |||
| Average Basic Shares Outstanding | 3.43% | 1.26% | |||
| Average Diluted Shares Outstanding | 3.43% | 1.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||